Australian Clinical Labs Limited (ASX: ACL)
Australia
· Delayed Price · Currency is AUD
3.470
+0.050 (1.46%)
Nov 21, 2024, 4:10 PM AEST
Australian Clinical Labs Company Description
Australian Clinical Labs Limited provides pathology diagnostic services in Australia.
The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services.
It offers its service to private and public hospitals. The company was incorporated in 2020 and is headquartered in Clayton, Australia.
Australian Clinical Labs Limited
Country | Australia |
Founded | 2020 |
Industry | Diagnostics & Research |
Sector | Healthcare |
Employees | 4,900 |
CEO | Melinda McGrath |
Contact Details
Address: 1868-1892 Dandenong Road Clayton, 3168 Australia | |
Phone | 61 1 3004 53688 |
Website | clinicallabs.com.au |
Stock Details
Ticker Symbol | ACL |
Exchange | Australian Securities Exchange |
Fiscal Year | July - June |
Reporting Currency | AUD |
ISIN Number | AU0000148496 |
SIC Code | 8071 |
Key Executives
Name | Position |
---|---|
Shae Seymour | Chief Executive Officer of WA/SA/NT |
Chris Brownlow | Chief Executive Officer of New South Wales and Australian Capital Territory |
Darren McKee | Chief Executive Officer of Victoria |
Melinda McGrath | Chief Executive Officer and Executive Director |
Matthew Cordingley | Chief Financial Officer |
Anthony Friedli | Chief Operating Officer |
Sean Jackson | Chief Information Officer |
Joe Geran | National Marketing Director |
Associate Prof. Tony Landgren | National Medical Director and Chief Pathologist |
Eleanor Padman B.A., FCIS | Company Secretary |